Moving Beyond mAbs: Level Up Your Knowledge Of Antibody-Derived Molecules

Source: Cytiva

Monoclonal antibodies (mAbs) have revolutionized therapeutics and led to the development of antibody variants like bispecific antibodies (bsAbs) and smaller antibody fragments. However, purifying these variants poses challenges due to their varying binding affinities and the need to separate impurities.

To address this, interactive courses are available to gain insights into mAbs and their variants, as well as purification strategies. These courses offer an overview of antibody variant structures, binding domains, and the pros and cons of different antibody fragments. They also guide on designing bsAbs and offer information on purification strategies, including chromatography steps, resin selection, and impurity removal during polishing.

Access the courses below to enhance your understanding of mAbs and their variants, enabling more effective purification strategies in therapeutic development.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Biosimilar Development? Subscribe today.

Subscribe to Biosimilar Development X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Biosimilar Development